“Growing Adoption of Minimally Invasive Endovascular Procedures”
One significant trend in the aneurysm treatment market is the growing adoption of minimally invasive endovascular procedures, which offer safer and more efficient alternatives to traditional open surgeries. These procedures, such as endovascular coiling and the use of flow-diverting stents, are increasingly preferred due to reduced recovery times and lower procedural risks. For instance, the WEB Aneurysm Embolization System by MicroVention has gained prominence as one of the most studied intrasaccular devices, with five-year follow-up data validating its efficacy and safety. Additionally, technological advancements such as AI-assisted tools, such as PreSize, enhance precision in treatment planning, further driving the adoption of these innovations. This trend is particularly strong in regions such as North America and Europe, where robust healthcare infrastructure supports the use of advanced medical technologies. As healthcare providers and patients continue to prioritize minimally invasive options, this trend is expected to propel the growth of the aneurysm treatment market in the coming years.
